SCHEMBL256765

SCHEMBL256765

C=C(C)c1cc(C(=O)c2ccccc2F)ccc1C(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.49
ALDH1A1 P00352 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.47
ITGB1 P05556 1/20 0.44
ITGA5 P08648 1/20 0.44
PYGL P06737 1/20 0.42
TSHR P16473 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
GAA P10253 2/20 0.42
KDM4E B2RXH2 4/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
POLB P06746 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ATM Q13315 2/20 0.41
CDC25A P30304 1/20 0.41
CDC25B P30305 1/20 0.41
ABCC9 O60706 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10047545 0.83 ALDH1A1 (0.55) KMT2AALDH1A1L3MBTL1PYGLTSHR
SCHEMBL257352 0.82 LMNA (0.54) KMT2AALDH1A1L3MBTL1PYGLTSHR
SCHEMBL10047113 0.81 KMT2A (0.51) KMT2AALDH1A1L3MBTL1PYGLTSHR
SCHEMBL15197128 0.81 ALDH1A1 (0.48) KMT2AALDH1A1ITGB1ITGA5TSHR
SCHEMBL256744 0.79 ALDH1A1 (0.49) KMT2AALDH1A1L3MBTL1ITGB1ITGA5
SCHEMBL17262494 0.77 KMT2A (0.44) KMT2AALDH1A1L3MBTL1TSHRCYP1A2
SCHEMBL10047114 0.77 ALDH1A1 (0.47) KMT2AALDH1A1L3MBTL1PYGLTSHR
SCHEMBL11760962 0.76 LMNA (0.59) KMT2AALDH1A1TSHRKDM4EMAPT
SCHEMBL15100959 0.76 ALDH1A1 (0.46) KMT2AALDH1A1L3MBTL1PYGLTSHR
SCHEMBL257672 0.76 ALDH1A1 (0.47) KMT2AALDH1A1L3MBTL1PYGLTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 KMT2A 1199/4885ALDH1A1 538/4885L3MBTL1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.